News
9h
The Healthy @Reader's Digest on MSN“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily ExerciseOvarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of ...
2d
MedPage Today on MSNPrimary Surgery for Ovarian Cancer Scores a Win -- Sort OfPrespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...
Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...
Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.
CBS Boston on MSN1d
A warning about an earlier outbreak of the Norovirus and a new way to detect ovarian cancerThe legal issues raised by Trump sending the National Guard to L.A. Mystery of America's 'Lost Colony' may finally be solved ...
Around one in 10 women will develop ovarian cysts at some point during their lives, and while the prospect of a cyst growing ...
3d
MedPage Today on MSNWin for Added Relacorilant in Platinum-Resistant Ovarian CancerIn addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...
Michele Hoaglund, who bought the store about a decade ago from its founding owners, was diagnosed with ovarian cancer around ...
ASCO 2025: Corcept Therapeutics’ relacorilant emerges as promising agent in recurrent ovarian cancer
Relacorilant blocks GR activation, a key pathway driving stress-induced chemoresistance in ovarian cancer cells.
Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.
Relacorilant/nab-paclitaxel significantly improved PFS and OS vs nab-paclitaxel alone in platinum-resistant ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results